Sleep Apnoea Quality of Life Index

Linda Sharples; Matthew Glover; Abigail Clutterbuck-James; Maxine Bennett; Jake Jordan; Rebecca Chadwick; Marcus Pittman; Clare East; Malcolm Cameron; Mike Davies; Nick Oscroft; Ian Smith; Mary Morrell; Julia Fox-Rushby; Timothy Quinnell

Warning: The NCBI web site requires JavaScript to function. more...

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Sharples L, Glover M, Clutterbuck-James A, et al. Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea–hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure. Southampton (UK): NIHR Journals Library; 2014 Oct. (Health Technology Assessment, No. 18.67.)

Cover of Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea–hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure

Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea–hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.

Show details

Contents

< Prev Next >

Appendix 3Sleep Apnoea Quality of Life Index

We would like to understand whether your sleep apnoea and/or snoring have had an impact on your daily activities, emotions, social interactions, and about symptoms that may have resulted.

Over the past 4 weeks:	Not at all	A little	Small to moderate amount	Moderate amount	Moderate to large amount	Large amount	Very large amount
How much have you had to push yourself to remain alert during a typical day (e.g. work, school, childcare, housework)?	□	□	□	□	□	□	□
How often have you had to use all your energy to accomplish your most important activity (e.g. work, school, childcare, housework)?	□	□	□	□	□	□	□
How much difficulty have you had finding the energy to do other activities (e.g. exercise, relaxing activities)?	□	□	□	□	□	□	□
How much difficulty have you had fighting to stay awake?	□	□	□	□	□	□	□
How much of a problem has it been to be told that your snoring is irritating?	□	□	□	□	□	□	□
How much of a problem have frequent conflicts or arguments been?	□	□	□	□	□	□	□
How often have you looked for excuses for being tired?	□	□	□	□	□	□	□
How often have you not wanted to do things with your family and/or friends?	□	□	□	□	□	□	□
How often have you felt depressed, down, or hopeless?	□	□	□	□	□	□	□
How often have you been impatient?	□	□	□	□	□	□	□
How much of a problem has it been to cope with everyday issues?	□	□	□	□	□	□	□
How much of a problem have you had with decreased energy?	□	□	□	□	□	□	□
How much of a problem have you had with fatigue?	□	□	□	□	□	□	□
How much of a problem have you had waking up feeling unrefreshed?	□	□	□	□	□	□	□

Copyright © Queen’s Printer and Controller of HMSO 2014. This work was produced by Sharples et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK.

Included under terms of UK Non-commercial Government License.

Bookshelf ID: NBK262707

Contents

< Prev Next >

PubReader
Print View
Cite this Page
Sharples L, Glover M, Clutterbuck-James A, et al. Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea–hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure. Southampton (UK): NIHR Journals Library; 2014 Oct. (Health Technology Assessment, No. 18.67.) Appendix 3, Sleep Apnoea Quality of Life Index.
PDF version of this title (3.8M)

Other titles in this collection

Health Technology Assessment

Recent Activity

Clear Turn Off Turn On

Sleep Apnoea Quality of Life Index - Clinical effectiveness and cost-effectivene...
Sleep Apnoea Quality of Life Index - Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea–hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure
Spontaneous Urinary Stone Passage ENabled by Drugs trial patient information lea...
Spontaneous Urinary Stone Passage ENabled by Drugs trial patient information leaflet - Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)
Behavioural activation clinical practice manual - Cost and Outcome of BehaviouRa...
Behavioural activation clinical practice manual - Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive–behavioural therapy for depression
Risk of bias for randomised controlled trials - Treatments for hyperemesis gravi...
Risk of bias for randomised controlled trials - Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessment
Participant results newsletter - Cost and Outcome of BehaviouRal Activation (COB...
Participant results newsletter - Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive–behavioural therapy for depression

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Bookshelf

Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea–hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure.

Appendix 3Sleep Apnoea Quality of Life Index

Views

Other titles in this collection

Recent Activity